Evaluation of the neurovirulence test for mumps vaccines

Biologicals

Volumn 27, Issue 1, 1999, Pages 43-49

  Afzal, M A ^a   Marsden, S A ^a   Hull, R M ^a   Pipkin, P A ^a   Bentley, M L ^a   Minor, P D ^a  

^a NATIONAL INSTITUTE FOR BIOLOGICAL STANDARDS AND CONTROL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

MUMPS VACCINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; EVALUATION; HUMAN; LABORATORY TEST; MACACA; MENINGITIS; NEUROLOGY; NONHUMAN; PRIORITY JOURNAL; QUALITY CONTROL; VIRUS STRAIN; VIRUS VIRULENCE;

ANIMALIA; MACACA; MACACA FASCICULARIS; RNA VIRUSES;

EID: 0032779920     PISSN: 10451056     EISSN: None     Source Type: Journal    
DOI: 10.1006/biol.1999.0174     Document Type: Article

References (20)

1. Russell RR, Donald JC. The neurological complications of mumps. Br Med J. 2:1958; 27-30.
2. Balraj V, Miller E. Complications of mumps vaccines. Rev Med Virol. 5:1995; 219-227.
3. Gordon NN. Experimental production of meningitis encephalaitis of mumps. Lancet. i:1927; 652-657.
4. Johnson CD, Goodpasture EW. An investigation of the aetology of mumps. J Exp Med. 59:1934; 1-19.
5. Wolinsky JS, Stroop WG. Virulence and persistence of three prototype strains for mumps virus in newborn hamsters. Arch Virol. 57:1978; 355-359.
6. Buynak EU, Hilleman MR. Live attenuated mumps virus vaccine. Proc Soc Exp Biol NY. 123:1966; 768-775.
7. Maximova O, Dragunsky E, Taffs R. Monkey neurovirulence test for live mumps vaccine. Biologicals. 24:1996; 223-224.
8. Levenbuk IS, Nickolayeva MA, Chigirinsky AE. On the morphological evaluation of the neurovirulence safety of attenuated mumps virus strains in monkeys. J Biol Stand. 7:1979;9-19.
9. Yuzepchuk SA, Rozina EE, Kaptsova TI. Morphological differences in the central nervous system and organs of monkeys inoculated intracerebrially with virulent and attenuated strains of mumps virus. Acta Virol. 19:1975; 305-310.
10. Rozina EE, Hilgenfeldt M. Comparative study of the neurovirulence of different vacciine strains of parotitis virus in monkeys. Acta Virol. 29:1985; 225-230.
11. Rubin SA, Pletnikov M, Carebone KM. Comparison of the neurovirulence of a vaccine and a mid type mumps virus strain in the developing rat brain. J Virol. 72:1998; 8037-8042.
12. WHO, Requirements for measles, mumps and rubella vaccines and combined vaccine (live). WHO Technical Report series, 1994; 840, 100, 176.
13. Sassani A, Mirchamsy H, Shafyi A. Development of a new live attenuated mumps virus vaccine in human diploid cells. Biologicals. 19:1991; 203-211.
14. Rozina EE, Kaftsova TI, Sharova OK. Study of mumps virus invasiveness in monkeys. Acta Virol. 28:1984; 107-113.
15. Afzal MA, Pickford AR, Forsey T. The Jeryl Lynn vaccine strain of mumps virus is a mixture of two distinct isolates. J Gen Virol. 74:1993; 917-920.
16. Afzal MA, Buchanan J, Dias JA. RT-PCR based diagnosis and molecular characterisation of mumps viruses derived from clinical specimens collected during the 1996 mumps outbreak in Portugal. J Med Virol. 52:1997; 349-353.
17. Brown EG, Dimmock K, Wright KE. The Urabe AM9 mumps vaccine is a mixture of viruses differing at amino acid 335 of the hemagglutinin-neuraminidase gene with one form associated with disease. J Infect Dis. 179:1996; 619-622.
18. Afzal MA, Yates PJ, Minor PD. Nucleotide Sequence at position 1081 of the hemagglutinin-neuraminidase gene in the mumps Urabe vaccine strain. J Infect Dis. 177:1998; 265-266.
19. Brown EG, Wright KE. Genetic studies on a mumps vaccine strain associated with meningitis. Rev Med Virol. 8:1998; 129-142.
20. Westrop GD, Wareham KA, Evans DMA. Genetic basis of attenuation of the Sabin type 3 oral poliovirus vaccine. J Virol. 63:1989; 1338-1344.